Understanding prostate disease is an important step toward finding the right care. Our Articles of Interest are designed to help you better understand prostate health, prostate disease, and today’s available treatment options. 

Whether you’re learning about prostate conditions, exploring innovative and incision‑free therapies, or preparing for a conversation with your healthcare provider, these articles offer clear, approachable information to support informed decision‑making—at your own pace and on your own terms.

NOTE: The following content is for educational purposes ONLY and should not replace medical advice from your physician.

In the United States, TULSA-PRO® has 510(k) regulatory clearance and is indicated for the ablation of prostate tissue, on the basis of clinical trials in men with localized prostate cancer where whole-gland ablation of benign and malignant prostate tissue demonstrated significant PSA reduction, prostate volume reduction, and follow-up biopsies that were negative for residual prostate cancer. As with other ablation devices, surgical robots, and radiotherapy machines, TULSA-PRO is a tool for the removal or destruction of prostate tissue; the effectiveness of TULSA-PRO or other devices in treating prostate cancer has not been established.